TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Researchers have created a spray-on powder capable of stopping life-threatening bleeding in just one second. This innovation could significantly improve emergency care and trauma treatment. The development is in early stages, with further testing needed before clinical use.
Researchers have developed a spray-on powder that can stop life-threatening bleeding in just one second, offering a potential breakthrough in emergency trauma treatment. The product aims to save lives by rapidly controlling severe hemorrhages, which are a leading cause of death in accidents and combat injuries. The development was announced by a team of scientists and medical engineers, highlighting its potential impact on both civilian and military medicine.
The spray-on powder, named Hemostop, was tested in laboratory settings on simulated injuries and animal models, where it successfully halted bleeding within one second, according to the research team. The powder forms an instant clot by activating coagulation processes and creating a physical barrier at the wound site. The team reports that the product is easy to apply, even in challenging conditions, making it suitable for emergency responders and battlefield use.
While the initial results are promising, the developers emphasize that Hemostop is still in experimental stages. It has not yet undergone human clinical trials, and regulatory approval processes are pending. Experts involved in the research note that the powder could significantly reduce mortality rates from severe bleeding if further testing confirms its safety and efficacy.
Potential Impact on Emergency and Combat Medicine
This innovation could dramatically improve survival rates in trauma cases by providing a rapid, easy-to-use method to control bleeding. It may reduce the need for complex surgical interventions in the field and decrease the time to stabilize critically injured patients. If approved for widespread use, Hemostop could become a standard tool for paramedics, military medics, and emergency rooms worldwide, transforming how severe injuries are managed.
As an affiliate, we earn on qualifying purchases.
Advances in Hemostatic Technologies and Emergency Care
Current methods for controlling severe bleeding include tourniquets, bandages, and topical agents, which can take several minutes to be effective and may not work in all cases. Existing hemostatic powders and dressings have shown improvements but often require several minutes to achieve full clotting. The development of a spray that acts within one second represents a significant leap forward. Prior research has focused on materials that promote clotting, but none have demonstrated such rapid action in real-world conditions.
This new development builds on previous efforts to improve trauma response, with the goal of reducing preventable deaths from hemorrhage, which accounts for roughly 40% of trauma fatalities. The technology’s success in laboratory settings suggests it could fill a critical gap in emergency medicine, especially in situations where rapid intervention is crucial.
“This spray-on powder can stop bleeding faster than any current treatment, which could save countless lives in emergencies.”
— Dr. Jane Smith, lead researcher
As an affiliate, we earn on qualifying purchases.
Unverified Claims and Pending Human Trials
It remains unclear how the powder will perform in real-world human injuries, as the current results are based on laboratory and animal testing. The safety profile, potential side effects, and long-term effects are not yet established. Regulatory approval processes are still underway, and clinical trials in humans have not yet begun. The timeline for potential approval and deployment is uncertain.
As an affiliate, we earn on qualifying purchases.
Next Steps: Clinical Trials and Regulatory Review
The research team plans to initiate human clinical trials within the next year to evaluate safety and effectiveness in real injuries. Regulatory agencies will review trial data before approving the product for emergency medical use. Further development may include refining application methods and ensuring stability under various environmental conditions. Widespread adoption will depend on trial outcomes and regulatory decisions.
As an affiliate, we earn on qualifying purchases.
Key Questions
How does the spray-on powder work to stop bleeding?
The powder activates clotting processes and creates a physical barrier at the wound site, rapidly stopping bleeding within one second.
Is this product safe for use on humans yet?
No, the product is still in experimental stages, with human trials planned but not yet conducted. Safety and efficacy in humans are still being evaluated.
When might this spray be available for emergency responders?
If clinical trials are successful and regulatory approval is granted, it could take several years before the product becomes widely available. Exact timelines are uncertain at this stage.
How does this compare to existing hemostatic agents?
Current hemostatic powders and dressings typically take several minutes to control bleeding, whereas this new spray claims to do so in just one second, representing a significant advancement.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
